Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the<i>F508del-CFTR</i>mutation

Details 詳細情報について

• CRID

  1360574094955753344

• DOI

  10.1136/thoraxjnl-2011-200393

• ISSN

  14683296

  00406376

• Web Site

  https://syndication.highwire.org/content/doi/10.1136/thoraxjnl-2011-200393

• Data Source

  • Crossref